February 6th 2026
Oral semaglutide (Wegovy; Novo Nordisk) expands GLP-1 weight-loss options, but pharmacy budgets and health care cost pressures persist.
Daniel J. Klein Outlines Patient Routes to Accessing Costly Medications
May 12th 2017According to Daniel J. Klein, president and CEO of the Patient Access Network Foundation, patients now have an easier time accessing the high-cost treatments they need, thanks to certain policies and programs. Klein also anticipates that a recently-passed law will bring down the prices of some prescription drugs.
Watch
Report Explores Characteristics of Single-Insurer Marketplace Regions
May 11th 2017A new report from the Urban Institute seeks to characterize the rating regions across the United States by the number of insurers offering plans in the healthcare marketplaces and found stark disparities in demographics, coverage, and price.
Read More